期刊
INTERNATIONAL JOURNAL OF NANOMEDICINE
卷 7, 期 -, 页码 4927-4942出版社
DOVE MEDICAL PRESS LTD
DOI: 10.2147/IJN.S35333
关键词
Alzheimer's disease; neuroinflammation; lipid-core nanocapsules; drug delivery; indomethacin; neuroprotection
资金
- Brazilian agency CAPES
- Brazilian agency FAPERGS
- Brazilian agency CNPq
- Brazilian agency CNPq-FAPERGS
- CAPES
- CNPq
Neuroinflammation, characterized by the accumulation of activated microglia and reactive astrocytes, is believed to modulate the development and/or progression of Alzheimer's disease (AD). Epidemiological studies suggesting that nonsteroidal anti-inflammatory drugs decrease the risk of developing AD have encouraged further studies elucidating the role of inflammation in AD. Nanoparticles have become an important focus of neurotherapeutic research because they are an especially effective form of drug delivery. Here, we investigate the potential protective effect of indomethacin-loaded lipid-core nanocapsules (IndOH-LNCs) against cell damage and neuroinflammation induced by amyloid beta (A beta)1-42 in AD models. Our results show that IndOH-LNCs attenuated A beta-induced cell death and were able to block the neuroinflammation triggered by A beta 1-42 in organotypic hippocampal cultures. Additionally, IndOH-LNC treatment was able to increase interleukin-10 release and decrease glial activation and c-jun N-terminal kinase phosphorylation. As a model of A beta-induced neurotoxicity in vivo, animals received a single intracerebroventricular injection of A beta 1-42 (1 nmol/site), and 1 day after A beta 1-42 infusion, they were administered either free IndOH or IndOH-LNCs (1 mg/kg, intraperitoneally) for 14 days. Only the treatment with IndOH-LNCs significantly attenuated the impairment of this behavior triggered by intracerebroventricular injection of A beta 1-42. Further, treatment with IndOH-LNCs was able to block the decreased synaptophysin levels induced by A beta 1-42 and suppress glial and microglial activation. These findings might be explained by the increase of IndOH concentration in brain tissue attained using drug-loaded lipid-core NCs. All these findings support the idea that blockage of neuroinflammation triggered by A beta is involved in the neuroprotective effects of IndOH-LNCs. These data provide strong evidence that IndOH-LNC treatment may represent a promising approach for treating AD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据